Skip to main content

Approaches to prevention of gynecological malignancies

Guest Editors

Federico Ferrari, MD, PhD, Department of Clinical and Experimental Sciences, University of Brescia, Italy
Andrea Giannini, MD, PhD, Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy

BMC Women's Health called for submissions to our Collection on Approaches to prevention of gynecological malignancies. 

This Collection aimed to consolidate current knowledge, share innovative strategies, and promote interdisciplinary research focused on preventing gynecological tumors. Gynecological malignancies pose a significant health challenge for women worldwide. Despite advances in diagnosis and treatment, prevention remains a crucial aspect of the fight against these cancers. The urgency surrounding the prevention of gynecological tumors stems from their high incidence and mortality rates, with these issues constituting a major global health challenge. Many gynecological malignancies are preventable through measures such as early screening and vaccination, making prevention a critical avenue for reducing the burden of these diseases. These tumors profoundly impact women's health, contribute to healthcare disparities, and carry substantial economic and societal costs. 

New Content ItemThis Collection supports and amplifies research related to SDG 3: Good Health and Well-Being and, SDG 5: Gender Equality.

Meet the Guest Editors

Back to top

Federico Ferrari, MD, PhD, Department of Clinical and Experimental Sciences, University of Brescia, Italy

Dr Ferarri is a clinician scientist in the field of gynecology oncology and cancer therapy and a lecturer as an Assistant Professor at the University of Brescia, Italy. His main research interests are the translational and clinical research setting in gynecologic oncology, in particular in all the aspects of prevention, diagnosis, surgical and medical treatment and follow-up. His particular research focus is oriented in surgical approaches for malignant disease, including minimally invasive surgery and the optimization of the patients’ management in this particular frame with a focus on ERAS programs and their interaction with long-term cancer outcomes. Regarding the lines of translational research, Dr Ferarri is involved in multicenter studies with active collaboration with national and international laboratories, in particular for the molecular classification of endometrial cancer and ovarian cancer genomic signature. At larger scales, he is committed to promoting international partnerships to enhance the evidence in my settings of activities and research.

Andrea Giannini, MD, PhD, Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Italy

Dr Giannini is a Specialist in Obstetrics and Gynecology at the University of Rome Sapienza, where he received a vote of 70/70 with honors. His research interests are in surgical and invasive medical procedures for gynecological tumors and diseases. He completed his PhD in Translational Medicine and Oncology and a degree in Medicine and Surgery, at the University of Rome Sapienza with a vote of 110/110 with honors. He successfully obtained his eligibility to practice Medicine in the Italian State Examination during the February 2015 session of the Registration in the Association of Physicians and Surgeons of Rome. Dr Giannini has coordinated and led multiple clinical trials assessing the efficacy and impact of treatments for gynecological malignancies. He also serves as an Editorial Board Member for the BMC Women’s Health journal.


About the Collection

BMC Women’s Health called for submissions to our Collection on Approaches to prevention of gynecological malignancies. 

Gynecological malignancies pose a significant health challenge for women worldwide. Despite advances in diagnosis and treatment, prevention remains a crucial aspect of the fight against these cancers. The urgency surrounding the prevention of gynecological tumors stems from their high incidence and mortality rates, with these issues constituting a major global health challenge. Many gynecological malignancies are preventable through measures such as early screening and vaccination, making prevention a critical avenue for reducing the burden of these diseases. These tumors profoundly impact women's health, contribute to healthcare disparities, and carry substantial economic and societal costs. 

This Collection aimed to consolidate current knowledge, share innovative strategies, and promote interdisciplinary research focused on preventing gynecological tumors. We encouraged researchers, clinicians, and experts in the field to contribute original research articles on topics including but not limited to advancements in screening, lifestyle interventions, vaccination programs, early detection methods, genetic predisposition assessment, and public health initiatives. 

This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being and, SDG 5: Gender Equality.

Image credit: Mariakray / stock.adobe.com 

  1. Intimate partner violence affects 20–30% of women in the United States. Disparities in routine cervical cancer surveillance have been demonstrated in certain populations, including victims of intimate partner ...

    Authors: Rachel A. Madding, Jessica J. Currier, Keenan Yanit, Madeline Hedges and Amanda Bruegl
    Citation: BMC Women's Health 2024 24:509
    Content type: Research Published on:

  2. The coronavirus 2019 (COVID-19) pandemic impacted cancer health care in several countries, with delays in the detection and treatment of breast and cervical cancer. The objective of this study is to analyze an...

    Authors: Kely Paviani Stevanato, Lander dos Santos, Fernando Castilho Pelloso, Deise Helena Pelloso Borghesan, Marcia Edilaine Lopes Consolaro, Rosane de Almeida, Isabela Morais Tavares Huber, Paulo Egger, Ana Carolina Jacinto Alarcão, Rebeca Rosa de Souza, Helena Fiats Ribeiro, Camila Wohlenberg Camparoto, Mariá Romanio Bitencourt, Pedro Beraldo Borba, Lincoln Luis Silva, Maria Dalva de Barros Carvalho…
    Citation: BMC Women's Health 2024 24:485
    Content type: Research Published on:

  3. Given the significant role of immune-related genes in uterine corpus endometrial carcinoma (UCEC) and the long-term outcomes of patients, our objective was to develop a prognostic risk prediction model using i...

    Authors: Qiu Sang, Linlin Yang, He Zhao, Lingfeng Zhao, Ruolan Xu, Hui Liu, Chunyan Ding, Yan Qin and Yanfei Zhao
    Citation: BMC Women's Health 2024 24:429
    Content type: Research Published on:

  4. Cervical cancer continues to disproportionately burden women in low/middle-income countries like Ghana. We examined treatment patterns and histopathological outcomes among women screened using visual inspectio...

    Authors: Kofi Effah, Ethel Tekpor, Comfort Mawusi Wormenor, Samuel Adolf Bosoka, Maxwell Afetor, Anita Edinam Dugbazah, Stephen Danyo, Esu Aku Catherine Morkli, Georgina Tay, Bernard Hayford Atuguba, Elorm Kpofo-Tetteh, Chrysantus Kubio and Nana Owusu Mensah Essel
    Citation: BMC Women's Health 2024 24:428
    Content type: Research Published on:

  6. Cytological screening remains a high-impact practice, particularly in low-resource settings, for preventing cervical cancer. The examination of screening practices over time and the prevalence of epithelial ab...

    Authors: Sahar Ezzelarab, Amro El-Husseiny, Magda Nasreldin, Radwa Ali and Ashraf Nabhan
    Citation: BMC Women's Health 2024 24:405
    Content type: Research Published on:

  7. Cervical cancer is one of the leading causes of death in women worldwide. The majority of the cases are found in developing countries. The increasing risk of cervical cancer prevalence and growing danger of de...

    Authors: Elfalet Worku, Getachew Yigizaw, Robel Admassu, Dawit Mekonnen, Winta Gessessa, Zemenu Tessema and Tarkie Walle
    Citation: BMC Women's Health 2024 24:322
    Content type: Research Published on:

  8. Gynecological malignancies represent one of the prevalent diseases in the female sex and prevention is essential to limit their incidence and mortality. Nowadays, not all malignancies benefit from adequate scr...

    Authors: Federico Ferrari and Andrea Giannini
    Citation: BMC Women's Health 2024 24:254
    Content type: Editorial Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Approaches to prevention of gynecological malignancies" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.